NextCell Pharma AB (NXTCL)
Stockholm Stock Exchange · Health Technology
NextCell Pharma AB stock (NXTCL): its screening is incomplete because its recent data does not match the latest financial statements we hold, the share count we hold for this company differs by more than 25% from the count implied by its market value; we wait until the two figures come close or the next financial statements are published, then give the result, per our screen under AAOIFI Shari'ah Standard No. 21 dated 2026-10-28.
- Price
- 0.30 SEKLast close 2026-10-27
- Market cap
- 54.22 M SEKat the 2026-10-27 close
- Symbol
- OMXSTO:NXTCL
- Market
- Stockholm Stock Exchange
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
Identity page only: this company is inside our coverage, but its fundamental figures are incomplete at the source, so it enters no scoring and no ranking.
Figures as of 2026-10-28 01:59
Sharia screening
Screening did not complete: the share's recent data does not match the latest financial statements we hold
We apply AAOIFI Shari'ah Standard No. 21, Financial Paper (Shares and Bonds), issued on 30 Rabi' I 1425 AH (20 May 2004), as published on AAOIFI's website. We last reviewed its limits on 2026-10-01. We read what the standard says; we do not issue fatwas.
This is an automated read of published screens, not a fatwa. We name what we ran; whatever we did not run stays outside the read.
We receive the ticker only, with no account and no email.
The screening of NextCell Pharma AB is not complete yet. The Sharia results for every stock on Stockholm Stock Exchange are in one free list. Open the free list
NextCell Pharma AB in numbers
NextCell Pharma AB ranks 101 of 116 in the Health Technology sector on Stockholm Stock Exchange by market cap (54.22 M SEK). Its debt-to-equity ratio is 0.
Published figures with their date, not financial advice. Market cap and P/E use the 2026-10-27 close.
The five screens, one by one
No score: the screen did not complete
No score: the screen did not complete
We ran 3 of 5 screens. The source labels its activity only in generic terms, which does not settle it, so there is no score until we screen its subsidiaries.
| Business activity (sector and industry) | Screening did not complete: the source labels its activity only in generic terms | |
| Interest-bearing debt to market cap | 0%, limit 30% | Passed |
| Cash and interest-bearing securities to market cap | 16%, limit 30% | Passed |
| Non-permissible income to revenue | 6.1%, limit 5% | Did not pass |
| Receivables to market cap | Not run: the standard sets no limit for it |
Purification share
We do not publish a per-share purification amount yet. The non-permissible income share appears on the 5% line when we measure it, and when we do not, we do not guess a figure.
Figures as of 2026-10-28 01:59
Company facts
- Debt-to-equity ratio 0
Figures computed from the company's published financial statements and read on 2026-10-28. They move with every new statement; this states a figure, it is an educational reading, not financial advice.
Fundamental filter
Below the stated threshold
- The company actually earned a profit over the last twelve months. Not met
- Its debt does not exceed twice its shareholders' equity. Met
Figures as of 2026-10-28
An automated quality screen on published figures, not financial advice. Every threshold is stated, every reason is named with its figure and its date, and the decision stays yours.
Frequently asked about NextCell Pharma AB
What is the sharia compliance score of NextCell Pharma AB?
NextCell Pharma AB: No score: the screen did not complete. The score out of 100 measures how far the debt and cash ratios sit from their stated limits; the five screens are broken down on this page.
Does NextCell Pharma AB stock need purification?
We do not publish a per-share purification amount yet. The non-permissible income share appears on the 5% line when we measure it, and when we do not, we do not guess a figure.
How do I work out zakat on NextCell Pharma AB shares?
The zakat calculator on this site gives an indicative amount from the value of the shares you hold; detailed rulings belong to scholars.
Which market lists NextCell Pharma AB?
NextCell Pharma AB is listed on Stockholm Stock Exchange under the symbol NXTCL.